Eli Lilly's GLP-1 drug is now the world's best-selling drug. Novo Nordisk is struggling with declining market share. Pfizer is desperately trying to get into the GLP-1 game. 10 stocks we like better ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google The writer and ...

Any additional downside for Bitcoin from current levels around $60,000 could further weigh on investor sentiment, said Matt Maley, a strategist at Miller Tabak. While Wall Street firms continue to ...

While blockbuster drugs like Wegovy and Zepbound are known for helping people lose weight, 44-year-old Paige Gordon is part of a new wave of people using them to treat their eating disorders instead.

For more than two decades, Paige Gordon chased a feeling of fullness. One night in college, she remembers eating an entire pizza, a bag of cookies, and a gallon of mint-chip ice cream while standing ...

Beginning Wednesday, Medicare will cover GLP-1 drugs for weight loss for the first time, with patients responsible for a $50-a-month co-payment that makes it far cheaper than cash prices without ...

The Centers for Medicare & Medicaid Services has announced the launch of a temporary Medicare GLP-1 Bridge program that will allow eligible Medicare Part D beneficiaries to access certain GLP-1 weight ...

John Wilkerson, a Washington correspondent, is the author of D.C. Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine. John writes about the politics of health ...